Chapin Davis, Inc. Astrazeneca PLC Transaction History
Chapin Davis, Inc.
- $362 Billion
- Q2 2025
A detailed history of Chapin Davis, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Chapin Davis, Inc. holds 3,675 shares of AZN stock, worth $274,044. This represents 0.07% of its overall portfolio holdings.
Number of Shares
3,675
Previous 3,873
5.11%
Holding current value
$274,044
Previous $285 Million
9.79%
% of portfolio
0.07%
Previous 0.1%
Shares
4 transactions
Others Institutions Holding AZN
# of Institutions
1,421Shares Held
507MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.26 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$3.03 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.66 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.37 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.33 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $231B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...